title: Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2. Comment on: "A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021".
authors.forename: Shao-Chuan
authors.initials: SC
authors.lastname: Wang
authors.forename: Fong-Lin
authors.initials: FL
authors.lastname: Chen
authors.forename: Wea-Lung
authors.initials: WL
authors.lastname: Lin
authors.forename: Po-Hui
authors.initials: PH
authors.lastname: Wang
authors.forename: Chih-Ping
authors.initials: CP
authors.lastname: Han
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D015415:Biomarkers; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D006801:Humans; D053538:Keratin-18 / Q000276:immunology*; D053533:Keratin-8 / Q000276:immunology*; D007633:Keratins / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D013274:Stomach Neoplasms / Q000473:pathology / Q000628:therapy
chemical_list: D000911:Antibodies, Monoclonal; D015415:Biomarkers; C400901:CAM 5.2 antigen; D053538:Keratin-18; D053533:Keratin-8; D007633:Keratins